Ornithine aspartate

门冬氨酸鸟氨酸

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOrnithine aspartate
Drug Alias NameL-ornithine L-aspartateHepa-MerzHepenax
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsDecompensated Liver CirrhosisHyperammonemiaAscites +[6] 
Global Approved IndicationsHyperammonemiaHepatic Encephalopathy
Approved Indications in ChinaHyperammonemia
Original Approved Country/TerritoryGermany
Original Approved Date1969/01/01
Country/TerritoryPakistanGermanyMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerz Pharma
China Registration ClassN/A

Develop Information

Active CompaniesMerz PharmaMerz + Co Gmbh & Co
Inactive CompaniesPeople'S Liberation Army Air Force Military Medical UniversityAga Khan University
Active IndicationsHyperammonemiaHepatic Encephalopathy
Inactive IndicationsDecompensated Liver CirrhosisAscitesVaricose Veins +[4] 

Other Information

ATC CodeA05
Related LinksWikipediaKEGG